Brooks Laboratories Limited (NSE:BROOKS)
68.55
+3.26 (4.99%)
Jun 1, 2026, 3:24 PM IST
Brooks Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 75.49 | 0.43 | 1.26 | 0.23 | 26.05 |
Cash & Short-Term Investments | 75.49 | 0.43 | 1.26 | 0.23 | 26.05 |
Cash Growth | 17293.78% | -65.42% | 440.95% | -99.11% | 194.72% |
Accounts Receivable | 161.15 | 199.92 | 163.16 | 127.54 | 176.62 |
Other Receivables | - | 11.4 | 17.65 | 3.03 | 13.69 |
Receivables | 161.15 | 211.33 | 180.84 | 130.57 | 190.31 |
Inventory | 110.22 | 92.05 | 96.11 | 113.03 | 275.22 |
Prepaid Expenses | - | 0.83 | 0.93 | 0.94 | 1.77 |
Other Current Assets | 27.3 | 34.12 | 31.36 | 31.29 | 118.47 |
Total Current Assets | 374.15 | 338.77 | 310.48 | 276.06 | 611.82 |
Property, Plant & Equipment | 157.09 | 139.72 | 136 | 148.09 | 1,245 |
Long-Term Investments | 923.41 | 735.54 | 429.13 | 640.26 | 2.78 |
Other Intangible Assets | - | 0.09 | 0.73 | 1.99 | 6.31 |
Long-Term Deferred Tax Assets | - | - | - | - | 13.55 |
Other Long-Term Assets | 27.08 | 22.82 | 28.11 | 29.57 | 79.75 |
Total Assets | 1,482 | 1,237 | 904.46 | 1,096 | 1,959 |
Accounts Payable | 114.37 | 136.24 | 154.43 | 233.7 | 280 |
Accrued Expenses | - | 21.96 | 16.54 | 23.18 | 32.34 |
Short-Term Debt | 60.87 | 59 | 50.42 | 56.64 | 110.47 |
Current Portion of Long-Term Debt | - | 0.33 | - | - | 38.76 |
Current Portion of Leases | 3.29 | 2.8 | 2.43 | 2.47 | 1.97 |
Other Current Liabilities | 39.61 | 8.11 | 6.65 | 14.23 | 25.25 |
Total Current Liabilities | 218.14 | 228.44 | 230.48 | 330.21 | 488.79 |
Long-Term Debt | 11.91 | 1.31 | - | - | 92.91 |
Long-Term Leases | 9.1 | 12.4 | 3.57 | 6.02 | 8.49 |
Pension & Post-Retirement Benefits | - | 6.37 | 6.8 | 9.03 | 12.96 |
Other Long-Term Liabilities | 16.02 | 7.39 | 7.76 | 11.17 | 12.78 |
Total Liabilities | 255.17 | 255.9 | 248.6 | 356.44 | 615.92 |
Common Stock | 294.57 | 294.57 | 262.47 | 247.03 | 247.03 |
Additional Paid-In Capital | - | 1,170 | 777.24 | 680 | 860.21 |
Retained Earnings | - | -486.52 | -386.85 | -190.93 | -236.18 |
Comprehensive Income & Other | 932 | 2.81 | 3 | 3.43 | 3.84 |
Total Common Equity | 1,227 | 981.04 | 655.85 | 739.53 | 874.9 |
Minority Interest | - | - | - | - | 468.29 |
Shareholders' Equity | 1,227 | 981.04 | 655.85 | 739.53 | 1,343 |
Total Liabilities & Equity | 1,482 | 1,237 | 904.46 | 1,096 | 1,959 |
Total Debt | 85.17 | 75.83 | 56.42 | 65.12 | 252.59 |
Net Cash (Debt) | -9.68 | -75.39 | -55.16 | -64.89 | -226.54 |
Net Cash Per Share | -0.33 | -2.81 | -2.15 | -2.63 | -9.17 |
Filing Date Shares Outstanding | 29.29 | 29.46 | 26.25 | 24.7 | 24.7 |
Total Common Shares Outstanding | 29.29 | 29.46 | 26.25 | 24.7 | 24.7 |
Working Capital | 156.01 | 110.33 | 80.01 | -54.15 | 123.04 |
Book Value Per Share | 41.88 | 33.30 | 24.99 | 29.94 | 35.42 |
Tangible Book Value | 1,227 | 980.95 | 655.12 | 737.55 | 868.59 |
Tangible Book Value Per Share | 41.88 | 33.30 | 24.96 | 29.86 | 35.16 |
Land | - | 15.13 | 15.13 | 15.13 | 187.13 |
Buildings | - | 38.89 | 38.89 | 38.45 | 447.98 |
Machinery | - | 166.2 | 160.19 | 156.49 | 771.88 |
Construction In Progress | - | - | - | - | 151.07 |